SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-136570
Filing Date
2016-08-03
Accepted
2016-08-03 16:31:49
Documents
47
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-11562_110q.htm 10-Q 927383
2 EX-31.1 a16-11562_1ex31d1.htm EX-31.1 13749
3 EX-31.2 a16-11562_1ex31d2.htm EX-31.2 13319
4 EX-32.1 a16-11562_1ex32d1.htm EX-32.1 6993
5 EX-32.2 a16-11562_1ex32d2.htm EX-32.2 6947
  Complete submission text file 0001104659-16-136570.txt   3979589

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT loxo-20160630.xml EX-101.INS 915138
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT loxo-20160630.xsd EX-101.SCH 27818
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT loxo-20160630_cal.xml EX-101.CAL 25983
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT loxo-20160630_def.xml EX-101.DEF 102691
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT loxo-20160630_lab.xml EX-101.LAB 286965
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT loxo-20160630_pre.xml EX-101.PRE 197453
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36562 | Film No.: 161804311
SIC: 2834 Pharmaceutical Preparations